CDK4 and CDK6 Inhibition in Breast Cancer - A New Standard
- PMID: 27959592
- DOI: 10.1056/NEJMe1611926
CDK4 and CDK6 Inhibition in Breast Cancer - A New Standard
Comment on
-
Palbociclib and Letrozole in Advanced Breast Cancer.N Engl J Med. 2016 Nov 17;375(20):1925-1936. doi: 10.1056/NEJMoa1607303. N Engl J Med. 2016. PMID: 27959613 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical